Vagal Nerve Stimulation for Chronic Constipation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

NeuromodulationFeb 27, 2026 (epub)
Clinical ResearchGastroenterology

Ahmad Omar Saleh, Ameer Awashra, Alaa Abdrabou Abouelmagd et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and random-effects meta-analysis of six randomized controlled trials assessed transcutaneous auricular vagus nerve stimulation and transcutaneous electroacupuncture for chronic constipation. Across 356 participants, vagal nerve stimulation was associated with improvements in pain, stool form, bowel movement frequency, and irritable bowel syndrome symptom severity. The largest reported bowel-frequency result was an increase of 1.75 weekly spontaneous bowel movements (mean difference 1.75; 95% CI 0.93-2.58; p < 0.0001). Anxiety, depression, and anorectal function did not differ significantly between groups.

Key findings

  • Weekly spontaneous bowel movements increased by a mean difference of 1.75 (95% CI 0.93-2.58; p < 0.0001).
  • Weekly complete spontaneous bowel movements increased (MD 1.10 [95% CI 0.40-1.80], p = 0.002).
  • Pain scores improved (MD -1.76 [95% CI -2.92 to -0.60], p = 0.003), as did Bristol stool form scores (MD 0.99 [95% CI 0.30-1.68], p = 0.005).
  • No significant between-group differences were found for anxiety, depression, or anorectal function.

Why it matters

Chronic constipation can substantially affect quality of life, and this synthesis suggests vagal nerve-based neuromodulation may improve bowel frequency and related symptoms. The findings provide a quantitative overview of outcomes from randomized trials, while the absence of significant effects on psychological measures and anorectal function indicates that benefits were not demonstrated across all assessed domains.

What to keep in mind

The evidence base comprised only six trials and 356 participants; the abstract does not report follow-up duration or provide details on variation among trial protocols.

Source

Published in Neuromodulation. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Gastroenterology

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.